What is a research inventory, and why does a neuropeptide bench need one?
A research inventory is a record of every physical lot of material a bench holds: what the compound is, which supplier and lot it came from, when it arrived, how much remains, and where it is stored. For a bench working in the cognitive and neuropeptide space, the record matters more than it might in other areas, because several of the compounds in this lane are fragile, closely related to one another, or heterogeneous by nature. A lyophilized heptapeptide such as Semax and a porcine-derived peptide mixture such as Cerebrolysin have very different handling histories, and a result that cannot be traced back to a specific lot is difficult to interpret or repeat.
Most benches begin with a spreadsheet, a notebook, or both. That works for a handful of items. It tends to degrade as the number of lots grows, as more than one person touches the shelf, and as older material sits through several rounds of freezer reorganization. Amino Axiom, a free research information platform, includes a research inventory that keeps this record at the vial level. This article compares the manual approach with that tool, using three Neurolevel catalog compounds as worked examples. It describes record keeping only; nothing here concerns use of any material outside of laboratory research.
What does a manual inventory usually look like?
A typical manual system is a single spreadsheet with one row per received item. Columns often include compound name, supplier, lot number, date received, quantity received, storage location, and a free-text notes field. A second layer lives on paper: handwritten labels on containers, a freezer map taped to a door, and a bench notebook that mentions lots in passing.
The manual approach has real strengths. It costs nothing, it is fully under the control of the person keeping it, and it can be shaped around any unusual requirement. Researchers who have kept good spreadsheets for years often have very clean records. The weaknesses are mostly about drift rather than design:
Naming is inconsistent. "Semax", "semax 5mg", and "SEMAX-A" can all appear in the same sheet, and filtering for one returns a partial result.
The sheet and the freezer disagree. Material is moved or consumed in experiments and the quantity column is updated later, or never.
Context lives somewhere else. The catalog number, the storage specification, and the molecular identity of the compound sit in supplier documents, not in the row.
Every row looks the same. A lot nearing the end of its useful life has no visual distinction from a fresh one.
None of these are failures of discipline so much as a consequence of using a general-purpose tool for a specific job.
What does the Amino Axiom research inventory track?
The inventory on Amino Axiom is organized around individual vials rather than around compounds. Each entry represents one physical container, and the entry is attached to a compound record in the platform's compound library. That attachment is the main structural difference from a spreadsheet: the compound is a defined entity rather than a typed string, so two entries for the same compound resolve to the same name every time.
Per entry, the inventory records the fields a bench actually needs to find and audit material: the compound, the supplier, the lot or batch reference, the received date, the quantity held, and a free-text note. Because entries are tied to the compound library, the identity information for that compound is reachable from the entry. For the Neurolevel catalog compounds used as examples below, that identity information is the same as what appears on the product pages, for instance Semax with CAS 80714-61-0, molecular formula C37H51N9O10S and molecular weight 813.93 g/mol.
The platform does not describe or imply any use of the material. It is a bookkeeping and information surface, and this article treats it as exactly that.
How does the comparison play out for Semax?
Semax is a good case for the comparison because it is a single, defined molecule with a published formula, a stable molecular weight, and a short sequence-derived identity. In a spreadsheet, the researcher types these facts into a notes column, usually once, usually from memory or a supplier sheet. If a second supplier is added later, the same facts get typed again, and small transcription errors become possible, especially in a formula with subscripts or a CAS number with a check digit.
In an inventory tied to a compound record, the identity facts are held once on the compound and referenced from each vial entry. A researcher auditing two lots of Semax from different suppliers sees them grouped under one compound, each with its own lot reference and received date. The practical gain is not speed so much as consistency: a query for the compound returns every vial, and the identity data does not depend on whoever filled in the row. Cross-checking the catalog values against a supplier certificate remains a manual scientific step in either system, and the inventory does not replace that review.
How does the comparison play out for Selank?
Selank illustrates a different problem: the naming trap. Selank is a synthetic analog of a naturally occurring tetrapeptide, and it is regularly discussed alongside Semax in the neuropeptide literature, since both were developed in the same research tradition. A bench that stocks both can easily end up with a spreadsheet where notes about one leak into rows about the other, particularly when entries are copied and edited.
Catalog identity for Selank in the Neurolevel catalog is CAS 129954-34-3, formula C33H57N11O9, molecular weight 751.86 g/mol. A vial-level inventory keeps each of the two compounds as a separate record, so a copied row cannot silently carry the wrong molecular data. When a bench later needs to answer a question such as "which lots of the Selank material have been on the shelf longest?", the answer is a filter on one compound, not a hand search through free-text notes.
This is also the situation where a comparison tool and an inventory are complementary. Amino Axiom's compound library lets a researcher read about related compounds side by side; the inventory then records which of those compounds are physically present. The two surfaces answer different questions, one about what a compound is and one about what is on the shelf.
How does the comparison play out for Cerebrolysin?
Cerebrolysin is the hardest case for any record system, and therefore the most instructive. It is a complex mixture of low-molecular-weight peptides and free amino acids from enzymatic hydrolysis of porcine brain tissue, catalogued under CAS 12656-61-0. The Neurolevel catalog lists its molecular weight as approximately 10,000 g/mol for the low-molecular-weight mixture and gives no single molecular formula, because a mixture does not have one.
For a mixture, lot-to-lot traceability carries more weight than it does for a defined single peptide. Published characterization work describes the preparation as variable in composition, so two lots are not guaranteed to be interchangeable for every assay. A spreadsheet with a vague "Cerebrolysin" label and a purchase date gives a researcher little to reason with when results differ between experiments run weeks apart. A vial-level entry with a lot reference, a received date, and a note about the assay it was allocated to makes the question answerable: which lot was in use for which experiment.
The inventory does not resolve the underlying scientific variability of the mixture. What it does is preserve the information needed for a researcher to notice it.
Where does the manual approach still win?
A fair comparison has to include the cases where a spreadsheet is the better tool.
Small benches. A bench with a few lots and one user gains little from a structured system. The overhead of entering each vial can exceed the benefit.
Highly custom columns. Benches that track instrument-specific fields, internal sample codes, or institutional barcodes may prefer a sheet built around those fields.
Offline and institutional requirements. Some institutions require records to live in a validated internal system, which no external platform replaces.
Control. A local file is entirely under the researcher's control. A hosted tool depends on the platform remaining available.
The inventory on Amino Axiom is best understood as an option for benches whose material count and number of contributors have outgrown a single sheet, not as a replacement that every bench needs.
How should a researcher read the inventory alongside supplier documents?
The inventory is a record of what a researcher has entered. It is not a verification of the material itself. Identity, purity, and handling statements come from supplier documentation and from the researcher's own analytical work, and the inventory entry should point back to those documents rather than stand in for them. A sound habit under either system is to record the lot reference exactly as printed on the container and the supplier document, and to treat any mismatch between the record and the container as a reason to stop and investigate before the material is used in an experiment.
Neurolevel's own catalog pages for Semax, Selank and Cerebrolysin list the specifications referenced above, and the full set is available in the compound catalog. Researchers interested in the tracking tool itself can find general information on the Amino Axiom site.
This compound is a research chemical intended for laboratory and scientific research purposes only. It is not a drug, supplement, or food, and is not intended to diagnose, treat, cure, or prevent any disease. Neurolevel does not sell products intended for human use. Researchers are responsible for compliance with all applicable local, state, and federal regulations.
